Biotech Values

[DewDiligence]

Tenders and corporate reorganizations in general can take a maddeningly long time for brokers to process. For instance, in the account I manage that previously owned AGN, the broker still shows fractional shares of ACT despite the fact that all fractional shares were converted into cash in the merger that closed in mid March.